Enhanced dissolution rate and oral bioavailability of Ginkgo biloba extract by preparing solid dispersion via hot-melt extrusion

Fitoterapia

Volumn 102, Issue , 2015, Pages 189-197

  Wang, Wenping ^a   Kang, Qian ^a   Liu, Na ^a   Zhang, Qing ^a   Zhang, Yewen ^a   Li, Hui ^a   Zhao, Bochen ^a   Chen, Yanyan ^a   Lan, Yi ^a   Ma, Qiang ^b   Wu, Qing ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Bioavailability; Dissolution rate; Ginkgo biloba extract; Hot melt extrusion; Solid dispersion

Indexed keywords

3-METHYLQUERCETIN; BILOBALIDE; CYCLOPENTANE DERIVATIVE; FURAN DERIVATIVE; GINKGOLIDE; GINKGOLIDE A; GINKGOLIDE B; GINKGOLIDE C; KAEMPFEROL; KAEMPFEROL DERIVATIVE; LACTONE; PLANT EXTRACT; QUERCETIN;

ANALOGS AND DERIVATIVES; ANIMAL; BIOAVAILABILITY; CHEMICAL STRUCTURE; CHEMISTRY; GINKGO BILOBA; MALE; SOLUBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; CYCLOPENTANES; FURANS; GINKGO BILOBA; GINKGOLIDES; KAEMPFEROLS; LACTONES; MALE; MOLECULAR STRUCTURE; PLANT EXTRACTS; QUERCETIN; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 84933038373     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2014.10.004     Document Type: Article

References (33)

1. C. Mancuso, R. Siciliano, E. Barone, and P. Preziosi Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine[J] Biochim Biophys Acta 1822 5 2012 616 624 10.1016/j.bbadis.2011.09.004
2. H. Kato-Noguchi, S. Takeshita, F. Kimura, O. Ohno, and K. Suenaga A novel substance with allelopathic activity in Ginkgo biloba[J] J Plant Physiol 170 18 2013 1595 1599 10.1016/j.jplph.2013.07.003
3. X.J. Xiong, W. Liu, X.C. Yang, B. Feng, Y.Q. Zhang, and S.J. Li Ginkgo biloba extract for essential hypertension: a systemic review[J] Phytomedicine 21 10 2014 1131 1136 10.1016/j.phymed.2014.04.024
4. S. Trumbeckaite, J. Bernatoniene, D. Majiene, V. Jakštas, A. Savickas, and A. Toleikis Effect of Ginkgo biloba extract on the rat heart mitochondrial function[J] J Ethnopharmacol 111 3 2007 512 516 10.1016/j.jep.2006.12.028
5. H. Wohlmuth, K. Savage, A. Dowell, and P. Mouatt Adulteration of Ginkgo biloba products and a simple method to improve its detection[J] Phytomedicine 21 6 2014 912 918 10.1016/j.phymed.2014.01.010
6. United States Pharmacopeial Convention United States Pharmacopeia 2011
7. M. Ellnain-Wojtaszek, Z. Kruczyński, and J. Kasprzak Investigation of the free radical scavenging activity of Ginkgo biloba L. leaves[J] Fitoterapia 74 1-2 2003 1 6
8. S.-Y. Huang, C. Jeng, S.-C. Kao, J.J.-H. Yu, and D.-Z. Liu Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy[J] Clin Nutr 23 4 2004 615 621 10.1016/j.clnu.2003.10.010
9. P. Singh, I.N. Singh, S.C. Mondal, L. Singh, and V.K. Garg Platelet-activating factor (PAF)-antagonists of natural origin[J] Fitoterapia 84 2013 180 201 10.1016/j.fitote.2012.11.002
10. Chinese Pharmacopoeia Commission Chinese Pharmacopoeia 2010 China Medical Science Press Beijing
11. F. Chen, L. Li, F. Xu, Y. Sun, F. Du, and X. Ma Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration[J] Br J Pharmacol 170 2 2013 440 457 10.1111/bph.12285
12. Y. Kawabata, K. Wada, M. Nakatani, S. Yamada, and S. Onoue Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications[J] Int J Pharm 420 1 2011 1 10 10.1016/j.ijpharm.2011.08.032
13. S.T. Buckley, K.J. Frank, G. Fricker, and M. Brandl Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations"[J] Eur J Pharm Sci 50 1 2013 8 16 10.1016/j.ejps.2013.04.002
14. Y. Yang, Q. Peng, and Y. Song Improvement of dissolution rate of Ginkgo biloba tablets by using solid dispersion[J] Chin New Drugs J 13 6 2004 521 524
15. J. Tang, J. Sun, F. Cui, T. Zhang, X. Liu, and Z. He Self-emulsifying drug delivery systems for improving oral absorption of Ginkgo Biloba extracts[J] Drug Deliv 45 8 2008 477 484
16. Y. Xiong, Z. Hu, J. Zhu, and J. Chen Study on pharmacokinetics of self-microemulsifying drug delivery system of Ginkgo Biloba extract 50[J] Tradit Chin Drug Res Clin Pharmacol 22 5 2011 542 545
17. Y. Xiong, Q. Liu, L. Lai, and J. Chen Preparation of the oral self-microemulsifying drug delivery system of GBE50[J] Acta Pharm Sin 44 7 2009 803 808
18. J. Tang, J. Sun, F. Cui, and Z. He Preparation of self-emulsifying drug delivery systems of Ginkgo biloba Extracts and In vitro Dissolution Studies[J] Asian J Tradit Med 1-4 2006
19. Z. Chen, J. Sun, D. Liu, Y. Xiao, and B. Cai Pharmacokinetics of Ginkgo biloba extract phospholipid complex in rats in vivo[J] Chin Tradit Pat Med 32 12 2010 2067 2070
20. Z.-p. Chen, J. Sun, H.-x. Chen, Y.-y. Xiao, D. Liu, and J. Chen Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats[J] Fitoterapia 81 8 2010 1045 1052 10.1016/j.fitote.2010.06.028
21. A. Semalty, M. Semalty, M.S.M. Rawat, and F. Franceschi Supramolecular phospholipids-polyphenolics interactions: The PHYTOSOME® strategy to improve the bioavailability of phytochemicals[J] Fitoterapia 81 5 2010 306 314 10.1016/j.fitote.2009.11.001
22. Shah S, Maddineni S, Lu J, Repka MA. Melt extrusion with poorly soluble drugs[J]. Int J Pharm, 0). http://dx.doi.org/10.1016/j.ijpharm.2012.11.001.
23. S. Sotthivirat, C. McKelvey, J. Moser, B. Rege, W. Xu, and D. Zhang Development of amorphous solid dispersion formulations of a poorly water-soluble drug MK-0364[J]. Int J Pharm, 0) 2013 10.1016/j.ijpharm.2013.04.037
24. N. Zajc, A. Obreza, M. Bele, and S. Srčič Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method[J] Int J Pharm 291 1-2 2005 51 58 10.1016/j.ijpharm.2004.07.042
25. L. Saerens, L. Dierickx, T. Quinten, P. Adriaensens, R. Carleer, and C. Vervaet In-line NIR spectroscopy for the understanding of polymer-drug interaction during pharmaceutical hot-melt extrusion[J] Eur J Pharm Biopharm 81 1 2012 230 237 10.1016/j.ejpb.2012.01.001
26. M.M. Crowley, F. Zhang, M.A. Repka, S. Thumma, S.B. Upadhye, and S.K. Battu Pharmaceutical applications of hot-melt extrusion: part I[J] Drug Dev Ind Pharm 33 9 2007 909 926 10.1080/03639040701498759
27. M.A. Repka, S.K. Battu, S.B. Upadhye, S. Thumma, M.M. Crowley, and F. Zhang Pharmaceutical applications of hot-melt extrusion: part II[J] Drug Dev Ind Pharm 33 10 2007 1043 1057 10.1080/03639040701525627
28. J. Li, Y. Shu, L. Dan, M. Ran, Yu. Ling, and Y. Wen The research progress of hot-melt extrusion technology applied in Chinese herbal medicine product[J] Pharm Clin Chin Mater Med 4 1 2013 60 63
29. Y. Lin, Y. Gu, X. Yan, R. Wang, T. Zhang, and R. Wang Evaluation of the dissolution of baicalin in Angong Niuhuang dispersion prepared by hot melt extrusion[J] Chin Tradit Pat Med 34 1 2012 38 41
30. R. Yang, X. Tang, and H.-f. Huang A preliminary evaluation of hot melt extrusion technology on improvement of silimarin dissolution[J] Chin New Drugs J 14 11 2005 1305 1308
31. Y.F. Luo, L.S. Xu, M. Xu, X.G. Tao, R.T. Ai, and X. Tang Improvement of dissolution and bioavailability of Ginsenosides by hot melt extrusion and cogrinding[J] Drug Dev Ind Pharm 39 1 2013 109 116 10.3109/03639045.2012.659189
32. W.-p. Wang, N. Liu, Q. Kang, P.-p. Du, Y. Lan, and B.-c. Zhao Simultaneous determination of seven bioactive compounds in rat plasma after oral administration of Ginkgo biloba tablets by UPLC-MS/MS: application to a pharmacokinetic study[J] J Zhejiang Univ Sci B 2014 10.1631/jzus.B1400035
33. P. Du, B. Zhao, W. Wang, J. An, Q. Wang, and N. Liu Studies on evaluation of sustained release tablets of extracts of Ginkgo biloba releasing rate in vitro by pharmacological indicatrix[J] China J Chin Mater Med 38 14 2013 2292 2296